Advertisement

Topics

Eiger Sells Cardiovascular Gene Therapy to Theragene in $18.1M Deal

10:16 EDT 29 Jun 2017 | PharmPro

Eiger BioPharmaceuticals announces sale of non-strategic assets to Theragene Pharmaceuticals.
Contributed Author: 
PR Newswire
Topics: 

Original Article: Eiger Sells Cardiovascular Gene Therapy to Theragene in $18.1M Deal

NEXT ARTICLE

More From BioPortfolio on "Eiger Sells Cardiovascular Gene Therapy to Theragene in $18.1M Deal"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Biotechnology Products
BioPortfolio lists over 550 biotechnology products - please open http://www.bioportfolio.com/channels?category_id=5 Direct topic pages: Actos Advair Biopharmaceuticals Biosimilars Biotherapeutics GMO Crops Lipitor ...